Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Advances in Risk Classification and Treatment Strategies for Neuroblastoma.
Haplotype-based analysis methods for population genomics
Phase I dose-escalation study of onartuzumab as a single agent and in combination with bevacizumab in patients with advanced solid malignancies.
Sex differences in proximal and distal nephron function contribute to the mechanism of idiopathic hypercalcuria in calcium stone formers.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Advances in Risk Classification and Treatment Strategies for Neuroblastoma.
Advances in Risk Classification and Treatment Strategies for Neuroblastoma. J Clin Oncol. 2015 Sep 20; 33(27):3008-17.
View in:
PubMed
subject areas
Adolescent
Age of Onset
Child
Child, Preschool
Cooperative Behavior
Diffusion of Innovation
Humans
Infant
Infant, Newborn
Interdisciplinary Communication
International Cooperation
Medical Oncology
Neuroblastoma
Pediatrics
Predictive Value of Tests
Risk Assessment
Risk Factors
Survivors
Time Factors
Treatment Outcome
Young Adult
authors with profiles
Susan Cohn
Samuel Volchenboum
Mark Applebaum